{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:14:14Z","timestamp":1765368854572},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Meningeal carcinomatosis (MC) is a rare complication associated with hematologic and solid tumors. MC develops when malignant cells gain access to the leptomeningeal space, producing several clinical symptoms. Loss of vision and ocular motility deficit are the most frequent ocular symptoms reported. Fundus examination usually appears normal, although optic nerve alterations like optic atrophy or papilledema have been described. MC diagnosis is usually completed by magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analysis. Indicated treatment for MC usually involves intrathecal chemotherapy combined with radiotherapy, although survival rate is extremely low.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 66-year old man with stage IV metastatic lung adenocarcinoma, presented to the Ophthalmology Department with a two-month history of double vision, soft headaches and dizziness episodes. The patient presented a best visual corrected acuity of 0.7 in his right eye and 0.8 in his left eye. Diplopia was corrected with 6-prism diopters base-out prism in right eye. Funduscopy showed a bilateral papilledema, juxtapapillary exudates and splinter hemorrhages. Brain MRI showed a diffuse leptomeningeal enhancement in cortical sulcus. Lumbar puncture was performed and cerebrospinal fluid (CSF) cytology revealed malignant cells compatible with a diagnosis of MC. Intrathecal chemotherapy was administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>MC is a serious complication of systemic cancer patients, involving a poor prognosis. Early diagnosis is extremely important, although treatment is frequently aimed to reduce the symptoms and extend survival. Eye symptoms may be the chief complaint, so MC should be considered in any patient with vision loss or diplopia accompanied by neurologic symptoms and in the absence of an intraocular cause, especially in the context of systemic cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2415-12-65","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T13:14:08Z","timestamp":1355836448000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Alfonso L","family":"Sabater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M","family":"Sadaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"de Nova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"292_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","volume":"5","author":"B Gleissner","year":"2006","unstructured":"Gleissner B, Chamberlain MC: Neoplastic meningitis. Lancet Neurol. 2006, 5: 443-452. 10.1016\/S1474-4422(06)70443-4.","journal-title":"Lancet Neurol"},{"key":"292_CR2","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1200\/JCO.2005.01.131","volume":"23","author":"MC Chamberlain","year":"2005","unstructured":"Chamberlain MC: Neoplastic meningitis. J Clin Oncol. 2005, 23: 3605-3613. 10.1200\/JCO.2005.01.131.","journal-title":"J Clin Oncol"},{"key":"292_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M Balm","year":"1996","unstructured":"Balm M, Hammack J: Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol. 1996, 53: 626-632. 10.1001\/archneur.1996.00550070064013.","journal-title":"Arch Neurol"},{"key":"292_CR4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.53.2.382","volume":"53","author":"RJ van Oostenbrugge","year":"1999","unstructured":"van Oostenbrugge RJ, Twijnstra A: Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology. 1999, 53: 382-385. 10.1212\/WNL.53.2.382.","journal-title":"Neurology"},{"key":"292_CR5","first-page":"681","volume":"52","author":"JL Katz","year":"1961","unstructured":"Katz JL, Valsamis MP, Jampel RS: Ocular signs in diffuse carcinomatous meningitis. AJOPHT. 1961, 52: 681-690.","journal-title":"AJOPHT"},{"key":"292_CR6","first-page":"965","volume":"10","author":"G Sze","year":"1989","unstructured":"Sze G, Soletsky S, Bronen R, Krol G: MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR Am J Neuroradiol. 1989, 10: 965-975.","journal-title":"AJNR Am J Neuroradiol"},{"key":"292_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995, 38: 51-57. 10.1002\/ana.410380111.","journal-title":"Ann Neurol"},{"key":"292_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982, 49: 759-772. 10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7.","journal-title":"Cancer"},{"key":"292_CR9","first-page":"639","volume":"15","author":"DJ Schumacher","year":"1994","unstructured":"Schumacher DJ, Tien RD, Friedman H: Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis. AJNR Am J Neuroradiol. 1994, 15: 639-641.","journal-title":"AJNR Am J Neuroradiol"},{"key":"292_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","volume":"223","author":"U Herrlinger","year":"2004","unstructured":"Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, Weller M: Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci. 2004, 223: 167-178. 10.1016\/j.jns.2004.05.008.","journal-title":"J Neurol Sci"},{"key":"292_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/A:1005956925637","volume":"38","author":"LM DeAngelis","year":"1998","unstructured":"DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol. 1998, 38: 245-252. 10.1023\/A:1005956925637.","journal-title":"J Neurooncol"},{"key":"292_CR12","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9","volume":"75","author":"MJ Glantz","year":"1995","unstructured":"Glantz MJ, Hall WA, Cole BF, Chozick BS, Shannon CM, Wahlberg L, Akerley W, Marin L, Choy H: Diagnosis, Management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer. 1995, 75: 2919-2931. 10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9.","journal-title":"Cancer"},{"issue":"11","key":"292_CR13","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/cncr.21082","volume":"103","author":"P Giglio","year":"2005","unstructured":"Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD: Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005, 103 (11): 2355-2362. 10.1002\/cncr.21082.","journal-title":"Cancer"},{"key":"292_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0733-8619(02)00032-4","volume":"21","author":"S Kesari","year":"2003","unstructured":"Kesari S, Batchelor TT: Leptomeningeal metastases. Neurol Clin. 2003, 21: 25-66. 10.1016\/S0733-8619(02)00032-4.","journal-title":"Neurol Clin"},{"key":"292_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.optm.2010.12.015","volume":"82","author":"J Walz","year":"2011","unstructured":"Walz J: Ocular manifestations of meningeal carcinomatosis: a case report and literature review. Optometry. 2011, 82: 408-412. 10.1016\/j.optm.2010.12.015.","journal-title":"Optometry"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-12-65\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:38:25Z","timestamp":1630532305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-12-65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-12-65","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"24 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}